Grimes & Company, Inc. Abiomed Inc Transaction History

Grimes & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$242.49 - $301.46 $245,884 - $305,680	1,014 New	1,014 $249,000
Q2 2022 Jul 22, 2022	SELL	$224.73 - $338.64 $137,984 - $207,924	-614 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$300.63 - $371.35 $18,037 - $22,281	-60 Reduced 8.9%	614 $221,000
Q2 2021 Aug 04, 2021	BUY	$262.71 - $351.17 $177,066 - $236,688	674 New	674 $210,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Grimes & Company, Inc. with notifications on news.